(3.238.107.166)
Users online: 2571    [ij] [ij] [ij] 
Email id
 

Research Journal of Pharmacy and Technology
Year : 2020, Volume : 13, Issue : 5
First page : ( 2159) Last page : ( 2162)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2020.00388.1

A Prospective Study of Propranolol and Flunarizine in the Prophylactic Therapy of Migraine in a Tertiary Care Hospital

Koshy Merin. T.1,*, Joseph Lincy2

1Assistant Professor, Department of Pharmacy Practice, KMCH College of Pharmacy, Coimbatore, Tamil Nadu

2Professor, Department of Pharmaceutical Chemistry, Pushpagiri College of Pharmacy, Thiruvalla, Kerala

*Corresponding Author E-mail: merintk7@gmail.com

Online published on 16 June, 2020.

Abstract

Migraine is a common, recurrent, severe headache that interferes with normal functioning and quality of life (QOL). This prospective observational study was conducted to evaluate and compare the effectiveness and safety flunarizine(10mg), calcium channel antagonist, and propranolol(40mg) in the prophylaxis of migraine with or without aura. This Study included 70 patients of migraine and was divided into 2 treatment groups. SF 36 v1 questionaire were used for the evaluation of health related QOL. Both treatment groups led to a significant reduction in severity, frequency and duration after one month. The difference between two treatments was statistically significant. Sedation was noted with both treatments. Propranolol can be the better treatment for reducing the severity and frequency of migraine.

Top

Keywords

Propranolol, flunarizne, migraine.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
459,969,240 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.